Pharsight Corporation Announces Fiscal Third Quarter 2006 Earnings Release Date And Conference Call

MOUNTAIN VIEW, Calif., Jan. 18 /PRNewswire-FirstCall/ -- Pharsight Corporation , a leading provider of software and strategic services designed to optimize clinical drug development, today announced that it will release financial results for the fiscal third quarter of 2006 ended December 31, 2005 after the market closes on Thursday, January 26, 2006. The Company will host a conference call and webcast on Thursday, January 26, 2006 at 1:30 p.m. Pacific Time to discuss the Company’s fiscal third quarter results, outlook for the remainder of fiscal 2006, and current corporate developments. The dial-in number for the conference call is 800- 366-7417 for domestic participants and 303-262-2143 for international participants.

A taped replay of the conference call will also be available beginning approximately one hour after the call’s conclusion and will remain available for seven days. This replay can be accessed by dialing 800-405-2236 for domestic callers and 303-590-3000 for international callers, using passcode 11051582#. To access the live webcast of the call, go to Pharsight’s website at www.pharsight.com. An archived webcast will also be available at www.pharsight.com.

About Pharsight Corporation

Pharsight Corporation develops and markets products and services that help pharmaceutical and biotechnology companies improve their decision-making in drug development and commercialization. By integrating scientific, clinical and business decision criteria into a dynamic, model-based methodology, Pharsight helps its customers optimize the value of their drug development programs and portfolios from discovery to post-launch marketing and any point in between. Pharsight uses computer-based drug-disease models, dynamic predictive market models, clinical trial simulation and advanced valuation models to create a continuously evolving view of its customers’ development efforts and product portfolios. This enables decision makers to make explicit value-driven trade-offs throughout the development and commercialization process. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available on the World Wide Web at www.pharsight.com.

Pharsight Corporation

CONTACT: investors, Douglas Sherk or Jennifer Beugelmans, +1-415-896-6820,or media, Steve DiMattia, +1-646-277-8706, all of EVC Group, for Pharsight

MORE ON THIS TOPIC